Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
Clinician,SMA treatments,"People with SMA types IIIb, IIIc and undefined III aged 18 years and under (symptomatic after 3 years of age)",SMA treatments (nusinersen/Spinraza and risdiplam/Evrysdi),,
